Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...
The Canadian Press on MSN21h
Australia wakes to more antisemitic graffiti after a discovery of explosives was revealed by policeThree more incidents of antisemitic graffiti were found across Sydney on Thursday morning, leading Australian political ...
Queen Mary of Denmark could secretly be planning another trip Down Under without her husband, King Frederik, royal watchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback